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Identity 
Other names: ps20 




The gene encompasses 35 kb of DNA; 7 exons. 
Transcription 
1366 nucleotides mRNA; 660 bp open reading frame. 
Protein 
Description 
220 amino acids; 24 kDa protein. Like rat ps20, human 
ps20 protein contains a WAP signature domain. 
Expression 
Widely expressed, absent in thymus. 
Function 
The rat homologue of ps20 was originally identified as 
a secreted growth inhibitor. These growth regulatory 
effects and the cell phenotypic properties in vitro, 
suggest that ps20 may function as a mediator of 
stromal-epithelial interactions and contribute to the 
maintenance of tissue homeostasis. The ps20 protein is 
assumed to function as a protease inhibitor. In vitro 
studies indicate that exogeneous addition of ps20 
protein stimulates endothelial cell migration, and 
promotes angiogenesis and tumour growth in a 
xenograft model of prostate cancer. 
Homology 
The human WFDC1 protein shares approximately 86% 
and 88% identity with the rat and mouse proteins, 
respectively. WFDC1 is related to a family of human 
proteins that also have homology with WAP. The 
WFDC1 gene organization presents similarities with 
that of the KAL gene, which extends on 210 kb of 
DNA, includes 14 exons and is the largest gene in the 
WAP signature domain family. 
 
Representation of the position of the conserved cysteines for the category of "four-disulfide core" domain and the location of the signature 
pattern for such a domain in the human WFDC1 amino acid sequence. 
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Although WFDC1 was mapped to human chromosome 
16q24, an area of frequent loss of heterozygosity 
(LOH) in prostate and hepatocellular carcinomas, no 
tumour-associated mutations were identified in the 
coding region of WFDC1 in these cancer types. 
Mutations in WFDC1 gene resulting in Gly9Asp, 
Pro211Ser and Lys217Arg substitutions have been 
found at low frequency in the stroma of breast 
carcinomas. One mutation resulting in a Pro167Ser 






WFDC1 is significantly down-regulated in prostate 
cancer making it a candidate tumour suppressor gene. 
However, WFDC1 seems predominantly expressed in 
the stroma of normal prostate. In tumors, decreased 
stromal WFDC1 expression has been associated with 
increased epithelial WFDC1 expression. This correlates 
with shorter recurrence-free survival times and may 
indicate progression to a more aggressive epithelial 
phenotype and an epithelial mesenchymal transition 
process. 
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